Company Filing History:
Years Active: 1990-1998
Title: Paul Gary Conway: Innovator in Ocular Therapeutics
Introduction
Paul Gary Conway is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of ocular therapeutics, holding 2 patents that focus on innovative solutions for intraocular pressure management.
Latest Patents
Conway's latest patents include a groundbreaking ocular composition that combines an ocular decongestant, such as phenylephrine, with specific labdane derivatives. This composition not only effectively reduces ocular reddening caused by labdane compounds but also unexpectedly prolongs and enhances their intraocular pressure lowering effects. These dual benefits are particularly advantageous for the treatment of glaucoma. Another notable composition described in his patents involves para-aminoclonidine, an α2-adrenoreceptor agonist, paired with the aforementioned labdane derivatives. This formulation also reduces ocular reddening and lacrimation while potentiating the intraocular pressure lowering effect.
Career Highlights
Throughout his career, Paul Gary Conway has worked with prominent companies in the pharmaceutical industry, including Hoechst Roussel Pharmaceuticals and Hoechst Marion Roussel. His experience in these organizations has contributed to his expertise in developing innovative ocular therapies.
Collaborations
Conway has collaborated with notable colleagues such as Grover C Helsley and Joachim Eggert Roehr, further enhancing his contributions to the field of ocular therapeutics.
Conclusion
Paul Gary Conway's work in developing ocular compositions demonstrates his commitment to advancing treatments for glaucoma and improving patient outcomes. His innovative approaches continue to influence the field of ocular therapeutics.